This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bessalle, R
Right arrow Articles by Fridkin, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bessalle, R
Right arrow Articles by Fridkin, M

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1992 February; 36(2): 313-317

Augmentation of the antibacterial activity of magainin by positive-charge chain extension.

R Bessalle, H Haas, A Goria, I Shalit and M Fridkin

Department of Organic Chemistry, Weizmann Institute of Science, Rehovot, Israel.

ABSTRACT

Novel analogs of the broad-spectrum antimicrobial peptide magainin-2 were obtained by extension of its chain through addition of segments of positively charged amino acids to either its N or its C terminus and by increasing its helicity. The activity of magainin-2 toward American Type Culture Collection strains of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus was most considerably enhanced by these modifications, whereas, in general, its low hemolytic capacity was not or was only slightly affected. The antibacterial potencies of magainin-2 and its derivatives were more evident following decreases of pH from 7.2 to 6 and 5.


Antimicrob Agents Chemother. 1992 February; 36(2): 313-317




This article has been cited by other articles:

  • Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., Barron, A. E. (2008). Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. USA 105: 2794-2799 [Abstract] [Full Text]  
  • Wei, G.-X., Bobek, L. A. (2005). Human Salivary Mucin MUC7 12-Mer-L and 12-Mer-D Peptides: Antifungal Activity in Saliva, Enhancement of Activity with Protease Inhibitor Cocktail or EDTA, and Cytotoxicity to Human Cells. Antimicrob. Agents Chemother. 49: 2336-2342 [Abstract] [Full Text]  
  • Yeaman, M. R., Yount, N. Y. (2003). Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacol. Rev. 55: 27-55 [Abstract] [Full Text]  
  • Bobek, L. A., Situ, H. (2003). MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action. Antimicrob. Agents Chemother. 47: 643-652 [Abstract] [Full Text]  
  • Tang, Y.-Q., Yeaman, M. R., Selsted, M. E. (2002). Antimicrobial Peptides from Human Platelets. Infect. Immun. 70: 6524-6533 [Abstract] [Full Text]  
  • Papo, N., Oren, Z., Pag, U., Sahl, H.-G., Shai, Y. (2002). The Consequence of Sequence Alteration of an Amphipathic alpha -Helical Antimicrobial Peptide and Its Diastereomers. J. Biol. Chem. 277: 33913-33921 [Abstract] [Full Text]  
  • Schwab, U., Gilligan, P., Jaynes, J., Henke, D. (1999). In Vitro Activities of Designed Antimicrobial Peptides against Multidrug-Resistant Cystic Fibrosis Pathogens. Antimicrob. Agents Chemother. 43: 1435-1440 [Abstract] [Full Text]